4,4,5,5-Tetramethyl-2-(1-methylcyclopropyl)-1,3,2-dioxaborolane, 97%, 100mg

2-((3,4-DIHYDROISOQUINOLIN-1-YL)METHYL)ISOINDOLINE-1,3-DIONE, 95.0%, 500mg

Dipropylene glycol monopropyl ether, min 98%, for synthesis, 2.5L, plastic packaging.

4-(2-Fluoro-3-nitrophenyl)pyridine, 98%, 250mg

4-Propylaniline, 95.0%, 500g

(1-(Trifluoromethyl)cyclopropyl)methanol, 95.0%, 250mg

2,2-Dimethyl-2,3-dihydrobenzofuran-4-carboxylic acid, 97%, 250mg

6-BROMO-1H-INDAZOL-4-AMINE, 95%, 100g

7-(prop-2-yn-1-yl)-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]thiazol-6(7H)-imine hydrobromide, 95.0%, 1g

5-Chloro-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxaldehyde, 95.0%, 10g

(Z)-4-OXO-4-(THIAZOL-2-YLAMINO)BUT-2-ENOIC ACID, 95.0%, 250mg

(1-(5-Methoxypyridin-2-yl)cyclohexyl)methanamine dihydrochloride, 98%, 1g

1-(4-Isopropylphenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde, 98%, 100mg